Research Article
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Figure 5
Persistence of NK-92 cells in vivo. (a) Continuous persistence of NK-92 cells in the blood of mice by FACS. (b) The quantitative analysis results of NK-92 cells in tumors by FACS. (c) Representative results of NK-92 cells in tumors shown in (b). NK-92 cells were stained with APC-conjugated anti-hCD56 and APC-Cy7-conjugated anti-hCD45 antibodies in all experiments. ; ; ns: not significant.
(a) |
(b) |
(c) |